| Date Filed | Type | Description |
| 06/15/2023 |
4
| Torres Denice (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 16,900 options to buy
@ $11.81, valued at
$199.6k
|
|
| 01/04/2023 |
4
| Torres Denice (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 1,572 shares
@ $0 |
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Torres Denice (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 8,200 shares
@ $0
Granted 16,900 options to buy
@ $13.51, valued at
$228.3k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Torres Denice (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 1,455 shares
@ $0 |
|
| 01/05/2022 |
4
| Torres Denice (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 12,000 options to buy
@ $5.08, valued at
$61k
|
|
| 11/17/2021 |
4
| Torres Denice (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Acquired 1,476 shares
@ $0
Disposed/sold 4,500 options to buy
@ $0
Disposed/sold 5,000 options to buy
@ $0 |
|
| 11/16/2021 |
4
| Torres Denice (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 492 shares
@ $0
Granted 2,002 shares
@ $0
Granted 1,476 options to buy
@ $102.14, valued at
$150.8k
Granted 3,219 options to buy
@ $50.98, valued at
$164.1k
|
|
| 10/18/2021 |
3
| Torres Denice (Director) has filed a Form 3 on 2seventy bio, Inc. |
| 08/03/2021 |
4
| Torres Denice (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 36,000 options to buy
@ $6.1, valued at
$219.6k
|
|
| 07/08/2021 |
3
| Torres Denice (Director) has filed a Form 3 on Surface Oncology, Inc. |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Torres Denice (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 3,079 shares
@ $0
Granted 449 shares
@ $0 |
|
| 03/03/2021 |
3
| Torres Denice (Director) has filed a Form 3 on GLAUKOS Corp |
| 12/22/2020 |
4
| Torres Denice (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $104.26, valued at
$2.6M
|
|
| 12/22/2020 |
3
| Torres Denice (Director) has filed a Form 3 on Karuna Therapeutics, Inc. |
| 08/11/2020 |
4
| Torres Denice (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 2,250 shares
@ $0
Granted 4,500 options to buy
@ $65.77, valued at
$296k
|
|
| 08/11/2020 |
3
| Torres Denice (Director) has filed a Form 3 on bluebird bio, Inc. |